Cargando…

Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis

Purpose: To evaluate the performance of an artificial intelligence (AI) algorithm in a simulated screening setting and its effectiveness in detecting missed and interval cancers. Methods: Digital mammograms were collected from Bahcesehir Mammographic Screening Program which is the first organized, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizildag Yirgin, Inci, Koyluoglu, Yilmaz Onat, Seker, Mustafa Ege, Ozkan Gurdal, Sibel, Ozaydin, Ayse Nilufer, Ozcinar, Beyza, Cabioğlu, Neslihan, Ozmen, Vahit, Aribal, Erkin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796113/
https://www.ncbi.nlm.nih.gov/pubmed/35060413
http://dx.doi.org/10.1177/15330338221075172
_version_ 1784641232474996736
author Kizildag Yirgin, Inci
Koyluoglu, Yilmaz Onat
Seker, Mustafa Ege
Ozkan Gurdal, Sibel
Ozaydin, Ayse Nilufer
Ozcinar, Beyza
Cabioğlu, Neslihan
Ozmen, Vahit
Aribal, Erkin
author_facet Kizildag Yirgin, Inci
Koyluoglu, Yilmaz Onat
Seker, Mustafa Ege
Ozkan Gurdal, Sibel
Ozaydin, Ayse Nilufer
Ozcinar, Beyza
Cabioğlu, Neslihan
Ozmen, Vahit
Aribal, Erkin
author_sort Kizildag Yirgin, Inci
collection PubMed
description Purpose: To evaluate the performance of an artificial intelligence (AI) algorithm in a simulated screening setting and its effectiveness in detecting missed and interval cancers. Methods: Digital mammograms were collected from Bahcesehir Mammographic Screening Program which is the first organized, population-based, 10-year (2009-2019) screening program in Turkey. In total, 211 mammograms were extracted from the archive of the screening program in this retrospective study. One hundred ten of them were diagnosed as breast cancer (74 screen-detected, 27 interval, 9 missed), 101 of them were negative mammograms with a follow-up for at least 24 months. Cancer detection rates of radiologists in the screening program were compared with an AI system. Three different mammography assessment methods were used: (1) 2 radiologists’ assessment at screening center, (2) AI assessment based on the established risk score threshold, (3) a hypothetical radiologist and AI team-up in which AI was considered to be the third reader. Results: Area under curve was 0.853 (95% CI = 0.801-0.905) and the cut-off value for risk score was 34.5% with a sensitivity of 72.8% and a specificity of 88.3% for AI cancer detection in ROC analysis. Cancer detection rates were 67.3% for radiologists, 72.7% for AI, and 83.6% for radiologist and AI team-up. AI detected 72.7% of all cancers on its own, of which 77.5% were screen-detected, 15% were interval cancers, and 7.5% were missed cancers. Conclusion: AI may potentially enhance the capacity of breast cancer screening programs by increasing cancer detection rates and decreasing false-negative evaluations.
format Online
Article
Text
id pubmed-8796113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87961132022-01-29 Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis Kizildag Yirgin, Inci Koyluoglu, Yilmaz Onat Seker, Mustafa Ege Ozkan Gurdal, Sibel Ozaydin, Ayse Nilufer Ozcinar, Beyza Cabioğlu, Neslihan Ozmen, Vahit Aribal, Erkin Technol Cancer Res Treat Original Article Purpose: To evaluate the performance of an artificial intelligence (AI) algorithm in a simulated screening setting and its effectiveness in detecting missed and interval cancers. Methods: Digital mammograms were collected from Bahcesehir Mammographic Screening Program which is the first organized, population-based, 10-year (2009-2019) screening program in Turkey. In total, 211 mammograms were extracted from the archive of the screening program in this retrospective study. One hundred ten of them were diagnosed as breast cancer (74 screen-detected, 27 interval, 9 missed), 101 of them were negative mammograms with a follow-up for at least 24 months. Cancer detection rates of radiologists in the screening program were compared with an AI system. Three different mammography assessment methods were used: (1) 2 radiologists’ assessment at screening center, (2) AI assessment based on the established risk score threshold, (3) a hypothetical radiologist and AI team-up in which AI was considered to be the third reader. Results: Area under curve was 0.853 (95% CI = 0.801-0.905) and the cut-off value for risk score was 34.5% with a sensitivity of 72.8% and a specificity of 88.3% for AI cancer detection in ROC analysis. Cancer detection rates were 67.3% for radiologists, 72.7% for AI, and 83.6% for radiologist and AI team-up. AI detected 72.7% of all cancers on its own, of which 77.5% were screen-detected, 15% were interval cancers, and 7.5% were missed cancers. Conclusion: AI may potentially enhance the capacity of breast cancer screening programs by increasing cancer detection rates and decreasing false-negative evaluations. SAGE Publications 2022-01-21 /pmc/articles/PMC8796113/ /pubmed/35060413 http://dx.doi.org/10.1177/15330338221075172 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Kizildag Yirgin, Inci
Koyluoglu, Yilmaz Onat
Seker, Mustafa Ege
Ozkan Gurdal, Sibel
Ozaydin, Ayse Nilufer
Ozcinar, Beyza
Cabioğlu, Neslihan
Ozmen, Vahit
Aribal, Erkin
Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
title Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
title_full Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
title_fullStr Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
title_full_unstemmed Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
title_short Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
title_sort diagnostic performance of ai for cancers registered in a mammography screening program: a retrospective analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796113/
https://www.ncbi.nlm.nih.gov/pubmed/35060413
http://dx.doi.org/10.1177/15330338221075172
work_keys_str_mv AT kizildagyirgininci diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT koyluogluyilmazonat diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT sekermustafaege diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT ozkangurdalsibel diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT ozaydinaysenilufer diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT ozcinarbeyza diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT cabiogluneslihan diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT ozmenvahit diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis
AT aribalerkin diagnosticperformanceofaiforcancersregisteredinamammographyscreeningprogramaretrospectiveanalysis